Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes
- 30 January 2021
- journal article
- research article
- Published by Elsevier BV in Med
- Vol. 2 (3), 313-320.e4
- https://doi.org/10.1016/j.medj.2021.01.005
Abstract
No abstract availableKeywords
Funding Information
- Centres de Recerca de Catalunya
- Instituto de Salud Carlos III
- Departament de Salut, Generalitat de Catalunya
This publication has 20 references indexed in Scilit:
- Immunological memory to SARS-CoV-2 assessed for up to 8 months after infectionScience, 2021
- Evolution of antibody immunity to SARS-CoV-2Nature, 2021
- Robust neutralizing antibodies to SARS-CoV-2 infection persist for monthsScience, 2020
- Infection fatality risk for SARS-CoV-2 in community dwelling population of Spain: nationwide seroepidemiological studyBMJ, 2020
- Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19The New England Journal of Medicine, 2020
- Clinical and immunological assessment of asymptomatic SARS-CoV-2 infectionsNature Medicine, 2020
- Neutralizing Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 in Coronavirus Disease 2019 Inpatients and Convalescent PatientsClinical Infectious Diseases, 2020
- Rapid Generation of Neutralizing Antibody Responses in COVID-19 PatientsCell Reports Medicine, 2020
- Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019Clinical Infectious Diseases, 2020
- Profile of specific antibodies to SARS-CoV-2: The first reportJournal of Infection, 2020